Prostaglandin E2 Stimulates the Growth of Human Blood CD34 Progenitors

[1]  V. Praloran,et al.  Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. , 1997, Journal of lipid mediators and cell signalling.

[2]  N. Nathan,et al.  Eicosanoid and cytokine levels in plasma of patients during mesenteric infarction , 1997, Mediators of inflammation.

[3]  F. Bertolini,et al.  Functional and Morphological Characterization of Immunomagnetically Selected CD34+ Hematopoietic Progenitor Cells , 1996, Stem cells.

[4]  Y. Denizot,et al.  Human bone marrow fibroblasts--an overview of their characterization, proliferation and inflammatory mediator production. , 1996, Hematology and cell therapy.

[5]  M. Fackler,et al.  CD34: structure, biology, and clinical utility. , 1996, Blood.

[6]  T. Luft,et al.  Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems , 1995, Stem cells.

[7]  A. Thiel,et al.  CD34+ human hemopoietic progenitor cells of the bone marrow differ from those of the peripheral blood: an immunocytochemical and morphometric study. , 1995, Acta haematologica.

[8]  T. Holyoake,et al.  CD34+ positive haemopoietic cells: biology and clinical applications. , 1994, Blood reviews.

[9]  D. Bonnet,et al.  Direct and reversible inhibitory effect of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Seraspenide) on the growth of human CD34+ subpopulations in response to growth factors. , 1993, Blood.

[10]  H. Mayani,et al.  Biology of the hemopoietic microenvironment , 1992, European journal of haematology.

[11]  L. To,et al.  Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. , 1991, Blood.

[12]  J. Falkenburg,et al.  Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure. , 1991, Lymphokine and cytokine research.

[13]  V. Dzau,et al.  Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease. , 1987, The American journal of cardiology.

[14]  A. Miller,et al.  Evidence for the role of leukotrienes C4 and D4 as essential intermediates in CSF-stimulated human myeloid colony formation. , 1986, Experimental hematology.

[15]  P. Blackshear,et al.  Plasma Level of 13,14-Dihydro-15-keto-PGE2 in Patients With Diabetic Ketoacidosis and in Normal Fasting Subjects , 1986, Diabetes.

[16]  J. Desforges,et al.  Lipoxygenase metabolites of arachidonic acid modulate hematopoiesis. , 1986, Blood.

[17]  R. Taetle,et al.  Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglandin E in chronic myeloproliferative disorders. , 1980, Experimental hematology.

[18]  W. Piacibello,et al.  Insensitivity of chronic myeloid leukemia cells to inhibition of growth by prostaglandin E1. , 1980, Cancer research.

[19]  C. Peschle,et al.  In vitro interactions of PGE and cAMP with murine and human erythroid precursors. , 1980, Blood.

[20]  R. Taetle,et al.  Effects of cyclic nucleotides and prostaglandins on normal and abnormal human myeloid progenitor proliferation. , 1980, Cancer Research.